| Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model T Yang, M Poenisch, R Khanal, Q Hu, Z Dai, R Li, G Song, Q Yuan, Q Yao, ... Journal of hepatology 75 (6), 1420-1433, 2021 | 113 | 2021 |
| The nuclear GUCT domain-containing DEAD-box RNA helicases govern gametophytic and sporophytic development in Physcomitrium patens PF Perroud, V Demko, AE Ako, R Khanal, B Bokor, A Pavlovič, J Jásik, ... Plant Molecular Biology 107 (4), 307-325, 2021 | 5 | 2021 |
| Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses N Heinen, R Khanal, S Westhoven, M Klöhn, ST Herrmann, M Herrmann, ... Gut 73 (10), e14-e14, 2024 | 4 | 2024 |
| Corrigendum to'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model'[J Hepatol (2021) 1420-1433] T Yang, M Poenisch, R Khanal, Q Hu, Z Dai, R Li, G Song, Q Yuan, Q Yao, ... Journal of hepatology 77 (1), 270, 2022 | 3 | 2022 |
| MicroRNAs modulate SARS‐CoV‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2 R Khanal, N Heinen, A Bogomolova, TL Meister, ST Herrmann, ... Liver International 44 (11), 2983-2995, 2024 | 1 | 2024 |
| Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis J Markovic, R Li, R Khanal, Q Peng, S Möbus, Q Yuan, B Engel, R Taubert, ... Journal of Hepatology, 2024 | | 2024 |
| Regulation of SARS-CoV-2 infection by microRNAs in primary human hepatocytes R Khanal, N Heinen, A Bogomolova, TL Meister, D Todt, F Jockenhövel, ... Zeitschrift für Gastroenterologie 62 (01), P5. 31, 2024 | | 2024 |
| MicroRNA-ITGA6/Has2 signaling regulates liver fibrosis R Khanal, J Markovic, R Li, H Büning, A Balakrishnan, M Ott, AD Sharma Zeitschrift für Gastroenterologie 61 (01), P1. 08, 2023 | | 2023 |
| Relevance of microRNAs in SARS-CoV-2 infection of primary human hepatocytes R Khanal, N Heinen, A Bogomolova, TL Meister, D Todt, F Jockenhövel, ... Zeitschrift für Gastroenterologie 61 (01), P5. 05, 2023 | | 2023 |
| mRNA therapeutics for liver diseases: HNF4A mRNA delivery via lipid nanoparticles attenuates liver fibrosis in preclinical models. R Khanal, T Yang, M Poenisch, R Taubert, B Engel, E Jaeckel, A Vogel, ... Zeitschrift für Gastroenterologie 60 (01), L 1.01, 2022 | | 2022 |
